论文部分内容阅读
目的观察氧气驱动硫酸沙丁胺醇气雾剂及异丙托溴铵雾化吸入治疗小儿哮喘的临床疗效。方法将126例哮喘患儿随机分为观察组和对照组各63例。对照组采用常规治疗,观察组在对照组治疗基础上给予异丙托溴铵及硫酸沙丁胺醇气雾剂氧气雾化吸入治疗。观察2组临床疗效,住院时间及临床症状、体征消失时间。结果观察组总有效率高于对照组,住院时间短于对照组,差异均有统计学意义(P<0.05)。观察组咳嗽、气喘、哮鸣音等症状消除时间均明显短于对照组,差异均有统计学意义(P<0.05)。结论氧气驱动硫酸沙丁胺醇气雾剂及异丙托溴铵雾化吸入治疗小儿哮喘有着良好的临床治疗效果,可以大大缩短患儿的住院时间,减轻患儿的痛苦,值得在临床上予以广泛推广和应用。
Objective To observe the clinical efficacy of aerosol salbutamol sulfate aerosol and ipratropium bromide inhalation in children with asthma. Methods 126 cases of asthma children were randomly divided into observation group and control group of 63 cases. The control group was treated with conventional therapy. The observation group was given ipratropium bromide and salbutamol sulfate aerosol inhalation based on the control group. The clinical efficacy, hospital stay, clinical symptoms and signs disappeared in 2 groups. Results The total effective rate of the observation group was higher than that of the control group, and the length of hospitalization was shorter than that of the control group (P <0.05). Observation group cough, asthma, wheeze and other symptoms were significantly shorter than the control group, the difference was statistically significant (P <0.05). Conclusion Oxygen-driven salbutamol sulfate aerosol and ipratropium bromide inhalation therapy have a good clinical treatment of pediatric asthma, which can greatly shorten the hospital stay in children, reduce the pain of children, it is worth to be widely promoted in clinical practice and application.